Schedule 13D ownership disclosure
Eleven Biotherapeutics, Inc.
Security class unavailable · CUSIP: 286221106
Event date: 2017-04-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-115091
- Form type
- SC 13D
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Apr 07, 2017
- Reporting period
- Apr 05, 2017
- Description
- Schedule 13D beneficial ownership